Aurinia Pharmaceuticals Inc. announced a $25 million bought-deal offering with a syndicate of underwriters led by H.C. Wainwright & Co. LLC and Cormark Securities Inc.

The company will issue 11,111,111 units at $2.25 apiece, complete with an option to purchase an additional 1,666,666 of the securities to raise a further $3.8 million. Each unit is made up of 1 company stock and one-half of a purchase warrant.

Every whole warrant will be exercisable into a company share for $3 apiece.

Aurinia plans to use the net proceeds for research and development activities with the offering closing Dec. 28.